[HTML][HTML] The cholesterol-binding sequence in monomeric c-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with …
H Li, N Gao, C Liu, X Liu, F Wu, N Dai, J Han… - Frontiers in …, 2022 - frontiersin.org
The receptor-binding domain (RBD) of the spike protein of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) binds to the human angiotensin-converting enzyme …
syndrome coronavirus 2 (SARS-CoV-2) binds to the human angiotensin-converting enzyme …
[HTML][HTML] Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
C Yi, X Sun, J Ye, L Ding, M Liu, Z Yang, X Lu… - Cellular & molecular …, 2020 - nature.com
Abstract Coronavirus disease 2019 (COVID-19), caused by the novel human coronavirus
SARS-CoV-2, is currently a major threat to public health worldwide. The viral spike protein …
SARS-CoV-2, is currently a major threat to public health worldwide. The viral spike protein …
Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain
I Anzai, J Fujita, C Ono, Y Kosaka… - Microbiology …, 2024 - Am Soc Microbiol
Although the global crisis caused by the coronavirus disease 2019 (COVID-19) pandemic is
over, the global epidemic of the disease continues. Severe acute respiratory syndrome …
over, the global epidemic of the disease continues. Severe acute respiratory syndrome …
[HTML][HTML] Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective
Abstract Background Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has
caused millions of infections and deaths worldwide since its discovery in late 2019 in …
caused millions of infections and deaths worldwide since its discovery in late 2019 in …
A hydrophobic‐interaction‐based mechanism triggers docking between the SARS‐CoV‐2 spike and angiotensin‐converting enzyme 2
J Li, X Ma, S Guo, C Hou, L Shi, H Zhang… - Global …, 2020 - Wiley Online Library
A recent experimental study found that the binding affinity between the cellular receptor
human angiotensin‐converting enzyme 2 (ACE2) and receptor‐binding domain (RBD) in the …
human angiotensin‐converting enzyme 2 (ACE2) and receptor‐binding domain (RBD) in the …
[HTML][HTML] LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
J Shilts, TWM Crozier, A Teixeira-Silva, I Gabaev… - PLoS …, 2023 - journals.plos.org
The interactions between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-
2) and human host factors enable the virus to propagate infections that lead to Coronavirus …
2) and human host factors enable the virus to propagate infections that lead to Coronavirus …
A hydrophobic-interaction-based mechanism trigger docking between the SARS CoV 2 spike and angiotensin-converting enzyme 2
J Li, X Ma, S Guo, C Hou, L Shi, H Zhang… - arXiv preprint arXiv …, 2020 - arxiv.org
A recent experimental study found that the binding affinity between the cellular receptor
human angiotensin converting enzyme 2 (ACE2) and receptor-binding domain (RBD) in …
human angiotensin converting enzyme 2 (ACE2) and receptor-binding domain (RBD) in …
Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism
H Othman, Z Bouslama, JT Brandenburg… - Biochemical and …, 2020 - Elsevier
The spread of COVID-19 caused by the SARS-CoV-2 outbreak has been growing since its
first identification in December 2019. The publishing of the first SARS-CoV-2 genome made …
first identification in December 2019. The publishing of the first SARS-CoV-2 genome made …
[HTML][HTML] Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor …
Abstract The outbreak of Coronavirus Disease 2019 (COVID-19) has posed a serious threat
to global public health, calling for the development of safe and effective prophylactics and …
to global public health, calling for the development of safe and effective prophylactics and …
[HTML][HTML] Unravelling the molecular interactions between the SARS-CoV-2 RBD spike protein and various specific monoclonal antibodies
Vaccination against SARS-CoV-2 just started in most of the countries. However, the
development of specific vaccines against SARS-CoV-2 is not the only approach to control …
development of specific vaccines against SARS-CoV-2 is not the only approach to control …